Qsam Biosciences, Inc
QSAM Biosciences, Inc. is a clinical stage company developing next-generation nuclear medicines for the treatment of cancer. Our lead product, Samarium-153 DOTMP (CycloSam®), is an advanced therapeutic radiopharmaceutical for multiple indications: treatment of primary bone cancer and metastatic bone cancers from the breast, prostate and lungs; bone marrow ablation; and reduction in external radiation. QSAM is not currently recruiting. To those receiving recruitment offers, this is unfortunately a scam and we advise you to cease any communications with any parties fraudulently representing QSAM.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
1
tools in use
Monthly traffic
60
organic / mo
Sign up free to see all 1 verified contacts at Qsam Biosciences, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Qsam Biosciences, Inc
1 distinct titles indexed · top 1 shown.
- 1executive chairman & co-founder
Sign up to unlock all 1 contacts at Qsam Biosciences, Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Qsam Biosciences, Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.